TY - JOUR
T1 - National institute on aging-Alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease
T2 - A practical approach
AU - Montine, Thomas J.
AU - Phelps, Creighton H.
AU - Beach, Thomas G.
AU - Bigio, Eileen H.
AU - Cairns, Nigel J.
AU - Dickson, Dennis W.
AU - Duyckaerts, Charles
AU - Frosch, Matthew P.
AU - Masliah, Eliezer
AU - Mirra, Suzanne S.
AU - Nelson, Peter T.
AU - Schneider, Julie A.
AU - Thal, Dietmar Rudolf
AU - Trojanowski, John Q.
AU - Vinters, Harry V.
AU - Hyman, Bradley T.
N1 - Funding Information:
Acknowledgments Support was provided by the National Institute on Aging (AG05134, AG05136, AG03991, AG05681, AG24904, AG28383, AG10161, AG17917, AG10124, AG13854, AG19610, NS62684, AG16570, AG15819, AG12435, AG05131, AG016976, AG16570, AG15866 and AG18840) as well as the Alzheimer’s Association, Arizona Department of Health Services (contract 211002, Arizona Alzheimer’s Consortium), Deutsche Forschungsgemeinschaft (DFG TH-624-4-1) and Alzheimer Forschung Initiative (AFI #10810), the Nancy and Buster Alvord Endowment, and the Charles and Joanne Knight Alzheimer Research Initiative. We thank Dr. Joshua Sonnen for providing some photomicrographs. The authors extend their deepest
PY - 2012/1
Y1 - 2012/1
N2 - We present a practical guide for the implementation of recently revised National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease (AD). Major revisions from previous consensus criteria are: (1) recognition that AD neuropathologic changes may occur in the apparent absence of cognitive impairment, (2) an "ABC" score for AD neuropathologic change that incorporates histopathologic assessments of amyloid β deposits (A), staging of neurofibrillary tangles (B), and scoring of neuritic plaques (C), and (3) more detailed approaches for assessing commonly co-morbid conditions such as Lewy body disease, vascular brain injury, hippocampal sclerosis, and TAR DNA binding protein (TDP)-43 immunoreactive inclusions. Recommendations also are made for the minimum sampling of brain, preferred staining methods with acceptable alternatives, reporting of results, and clinico-pathologic correlations.
AB - We present a practical guide for the implementation of recently revised National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease (AD). Major revisions from previous consensus criteria are: (1) recognition that AD neuropathologic changes may occur in the apparent absence of cognitive impairment, (2) an "ABC" score for AD neuropathologic change that incorporates histopathologic assessments of amyloid β deposits (A), staging of neurofibrillary tangles (B), and scoring of neuritic plaques (C), and (3) more detailed approaches for assessing commonly co-morbid conditions such as Lewy body disease, vascular brain injury, hippocampal sclerosis, and TAR DNA binding protein (TDP)-43 immunoreactive inclusions. Recommendations also are made for the minimum sampling of brain, preferred staining methods with acceptable alternatives, reporting of results, and clinico-pathologic correlations.
UR - http://www.scopus.com/inward/record.url?scp=84857030932&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857030932&partnerID=8YFLogxK
U2 - 10.1007/s00401-011-0910-3
DO - 10.1007/s00401-011-0910-3
M3 - Article
C2 - 22101365
AN - SCOPUS:84857030932
SN - 0001-6322
VL - 123
SP - 1
EP - 11
JO - Acta Neuropathologica
JF - Acta Neuropathologica
IS - 1
ER -